openPR Logo

Press Releases from Dermatomyositis Therapeutics- Pharma Proff (1 total)

Dermatomyositis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results, …

Dermatomyositis is a rare inflammatory disease which can occur in any age. However, it is most common in children age group of 5 to 15 years, and people of late 40's and early 60's. Download the sample report at: https://www.pharmaproff.com/request-sample/1013 Some of the most common symptoms observed in patients with dermatomyositis are erythema, inflammatory myopathy, myalgia, progressive muscle weakness, eyelid abnormality, and periorbital edema. The cause of the disease is still

Go To Page:   1 2 3 4 5 6 7 8 9 10